Form 4: Qualys Director Sells Shares Under Pre-Arranged Plan

Qualys Director Thomas Berquist sold 512 shares of common stock on September 2, 2025, under a Rule 10b5-1 trading plan.

Summary

• Thomas Berquist, a Director of Qualys, Inc. (QLYS), reported the sale of 512 shares of common stock.
• The sales occurred on September 2, 2025, through three separate transactions.
• The first transaction involved 150 shares at a weighted average price of $132.1767 per share, with prices ranging from $131.55 to $132.50.
• The second transaction involved 325 shares at a weighted average price of $133.4115 per share, with prices ranging from $132.93 to $133.78.
• The third transaction involved 37 shares at a price of $133.93 per share.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Berquist on February 19, 2025.
• Following these transactions, Mr. Berquist directly beneficially owns 5,092 shares of Qualys common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan, which is a neutral event for the company's operational or financial performance.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which demonstrates pre-planning and adherence to regulatory guidelines for insider transactions, mitigating concerns about trading on material non-public information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived by some investors as a signal, though for 10b5-1 plans, it is typically for personal financial management rather than a reflection of company outlook.

Risks

• While the sale was pre-planned, significant or repeated insider selling could potentially be interpreted by the market as a lack of confidence, which might put downward pressure on the stock price.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2025.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are a common practice in the public markets. These plans allow corporate insiders to sell a predetermined number of shares at a predetermined time or price, providing an affirmative defense against claims of insider trading. This is a standard mechanism for executives and directors to manage their personal finances while adhering to SEC regulations.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, pre-planned insider sale. May lead to minor, short-term sentiment shifts depending on market interpretation of insider selling.
• Employees, Customers, Suppliers, Creditors: No direct impact from this filing.

Key Dates

Recommendation

The filing details a pre-scheduled insider stock sale by a director under a Rule 10b5-1 plan. Such routine transactions are generally for personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant an alteration to an existing investment thesis. Therefore, a 'hold' recommendation is appropriate as this event does not provide new information to fundamentally change the investment case for Qualys.

Keywords

Qualys, QLYS, Insider Trading, Form 4, Stock Sale, Director, Thomas Berquist, 10b5-1 Plan